Trial intelligence / Profile preview

DNA Vaccination in Chronic Hepatitis B Patients Under NRTI Treatment

NCT00536627Phase 2Completed

Sponsor
ANRS
Start
Jan 2008
Primary completion
Nov 2010
Modality
Prophylactic Vaccines, Gene Editing, Gene Silencing
Countries
1
01

Overview

A Phase 2 trial of pCMV-S2.S in Chronic Hepatitis B (CHB), sponsored by ANRS. Started Jan 2008; status: completed.

02

Drugs

pCMV-S2.S
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT00536627.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00536627.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call